OCTAPHARMA AG
Patent Owner
Stats
- 32 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 32 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 535 Total Citation Count
- Dec 24, 1991 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0189,494 PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIMar 20, 17Jul 06, 17[A61K]
2016/0340,410 A PROCESS FOR MANUFACTURING FACTOR VIII HAVING AN IMPROVED RATIO OF FVIII:C/FVIII:AGJan 20, 15Nov 24, 16[C07K]
2016/0152,661 PROCESS FOR ISOLATION AND PURIFICATION OF A TARGET PROTEIN FREE OF PRION PROTEIN (PRPSC)Dec 29, 15Jun 02, 16[C07K, B01D]
2015/0190,478 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIDec 11, 14Jul 09, 15[A61K]
2013/0079,498 PROCESS FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IXMar 30, 11Mar 28, 13[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9901597 Method for inactivation/removal of coagulation factors by precipitationFeb 03, 12Feb 27, 18[A61K, C07K]
9796986 Serum-free stable transfection and production of recombinant human proteins in human cell linesDec 05, 16Oct 24, 17[C12N, C07K]
9512457 Serum-free stable transfection and production of recombinant human proteins in human cell linesFeb 01, 16Dec 06, 16[C12P, C12N, C07K]
9388402 Method for improved isolation of recombinantly produced proteinsMar 29, 06Jul 12, 16[C12P, C12N, C07K]
9120873 Recombinantly produced human factor VIII and IXAug 21, 09Sep 01, 15[A61K, C07H, C12P, C12N, C07K]
9115381 Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIIIMay 14, 12Aug 25, 15[C12P, C12N, C07K]
8962813 Purification and use of a factor for supporting wound healingJan 25, 07Feb 24, 15[A61K, A23J, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0250,879 TEST FOR HEMOLYTIC POTENTIAL OF PHARMACEUTICAL PRODUCTS AND FORMULATIONS FOR RISK MINIMIZATIONAbandonedSep 26, 13Sep 10, 15[A61K, G01N, C07K]
2014/0051,839 Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation FactorsAbandonedNov 16, 11Feb 20, 14[C07K]
8518452 Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acidExpiredFeb 15, 08Aug 27, 13[A61K]
2011/0178,019 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIAbandonedSep 03, 09Jul 21, 11[A61K, A61P]
2011/0104,298 Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasmaAbandonedAug 24, 10May 05, 11[A61K]
2010/0330,568 ASSAY AND METHOD FOR THE ASSESSMENT OF RESPONDERS AND NON-RESPONDERS TO NK CELL MODULATION BY IMMUNOGLOBULIN THERAPYAbandonedJan 09, 09Dec 30, 10[C12Q]
2008/0172,902 Lyophilisation targeting defined residual moisture by limited desorption energy levelsAbandonedJun 19, 07Jul 24, 08[F26B]
2007/0071,829 Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasmaAbandonedDec 20, 04Mar 29, 07[A61K, C12N]
2006/0234,907 Albumin solution and process for the production thereofAbandonedFeb 13, 04Oct 19, 06[C07K]
2006/0194,300 Process for preparing an alpha-1-antitrypsin solutionAbandonedAug 12, 04Aug 31, 06[C12N]
6893856 Process for preparing virus-inactivated factors 1X and X by membrane chromatographyExpiredMay 02, 02May 17, 05[C12N, C02F]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.